Kyle Y. Faget

Health Care Marketing: The Seventh Circuit Addresses "Referrals" Under The Anti-Kickback Statute

MedTech Round Table: What The Trump Administration Means For Companies And Investors

Prescription Drugs: Executive Order Aims To Lower Prices

Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule

Compounded GLP-1 Drugs: Texas Judge Denies PI Motion And Request For Stay Of FDA's Declaration That Tirzepatide Shortage Is Resolved; Plaintiff OFA Appeals

FDA & OHRP Draft Guidance: Including Tissue Biopsies In Clinical Trials

Scientific Information On Unapproved Uses Of Medical Products: FDA's Final Guidance On Firm Communication To Health Care Providers

AI-Enabled Device Software Functions: FDA's Final Guidance For Predetermined Change Control Plans

GLP-1 Drugs: FDA "Re-Confirms" Decision Removing Tirzepatide From The Drug Shortage List

Private Equity: Senators Markey And Braun Seek Information On Role In Treatment For Opioid Use Disorder